BioStock: Chordate’s CEO on entering new markets

How does Chordate Medical’s treatment for rhinitis and chronic migraine work? What market interest has the company seen and what strategy is it working with to gain market share? In connection with the BioStock Investor Meeting, the company’s CEO Anders Weilandt talked about this, among other things.

Watch the interview with Anders Weilandt at biostock.se:

https://www.biostock.se/en/2023/03/chordates-ceo-on-entering-new-markets/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/